| Molecular subgrouping of atypical teratoid/rhabdoid tumors—a reinvestigation and current consensus B Ho, PD Johann, Y Grabovska, MJ De Dieu Andrianteranagna, F Yao, ... Neuro-oncology 22 (5), 613-624, 2020 | 195 | 2020 |
| Pediatric pan-central nervous system tumor analysis of immune-cell infiltration identifies correlates of antitumor immunity Y Grabovska, A Mackay, P O’Hare, S Crosier, M Finetti, EC Schwalbe, ... Nature communications 11 (1), 1-15, 2020 | 107 | 2020 |
| DNA methylation-based profiling for paediatric CNS tumour diagnosis and treatment: a population-based study JC Pickles, AR Fairchild, TJ Stone, L Brownlee, A Merve, SA Yasin, ... The lancet child & adolescent health 4 (2), 121-130, 2020 | 83 | 2020 |
| Time, pattern, and outcome of medulloblastoma relapse and their association with tumour biology at diagnosis and therapy: a multicentre cohort study RM Hill, S Richardson, EC Schwalbe, D Hicks, JC Lindsey, S Crosier, ... The Lancet Child & Adolescent Health 4 (12), 865-874, 2020 | 80 | 2020 |
| RUNX1-ETO and RUNX1-EVI1 Differentially Reprogram the Chromatin Landscape in t (8; 21) and t (3; 21) AML J Loke, SA Assi, MR Imperato, A Ptasinska, P Cauchy, Y Grabovska, ... Cell reports 19 (8), 1654-1668, 2017 | 57 | 2017 |
| Platelet-derived growth factor beta is a potent inflammatory driver in paediatric high-grade glioma JL Ross, Z Chen, CJ Herting, Y Grabovska, F Szulzewsky, M Puigdelloses, ... Brain 144 (1), 53-69, 2021 | 55 | 2021 |
| Medulloblastoma group 3 and 4 tumors comprise a clinically and biologically significant expression continuum reflecting human cerebellar development D Williamson, EC Schwalbe, D Hicks, KA Aldinger, JC Lindsey, S Crosier, ... Cell Reports 40 (5), 111162, 2022 | 42 | 2022 |
| Molecular landscape of IDH-mutant primary astrocytoma Grade IV/glioblastomas QHW Wong, KKW Li, WW Wang, TM Malta, H Noushmehr, Y Grabovska, ... Modern Pathology 34 (7), 1245-1260, 2021 | 37 | 2021 |
| Translational genomics of malignant rhabdoid tumours: current impact and future possibilities MA Finetti, Y Grabovska, S Bailey, D Williamson Seminars in Cancer Biology 61, 30-41, 2020 | 23 | 2020 |
| DIPG harbour alterations targetable by MEK inhibitors, with acquired resistance mechanisms overcome by combinatorial inhibition E Izquierdo, DM Carvalho, A Mackay, S Temelso, JKR Boult, G Pericoli, ... Cancer Discovery, 2021 | 22 | 2021 |
| DIPG HARBOUR ALTERATIONS TARGETABLE BY MEK INHIBITORS, WITH ACQUIRED RESISTANCE MECHANISMS OVERCOME BY COMBINATORIAL INHIBITION E Izquierdo, D Carvalho, A Mackay, S Temelso, JKR Boult, V Molinari, ... NEURO-ONCOLOGY 22, 62-62, 2020 | 22 | 2020 |
| Inter and intra-tumor heterogeneity of paediatric type diffuse high-grade gliomas revealed by single-cell mass cytometry LL Petrilli, C Fuoco, A Palma, L Pasquini, G Pericoli, Y Grabovska, ... Frontiers in Oncology 12, 6821, 2022 | 7 | 2022 |
| Drug screening linked to molecular profiling identifies novel dependencies in patient-derived primary cultures of paediatric high grade glioma and DIPG DM Carvalho, S Temelso, A Mackay, HN Pemberton, R Rogers, K Kessler, ... bioRxiv, 2020 | 7 | 2020 |
| Multiomics Analysis of IMiD/CELMoD Resistant Multiple Myeloma Models Uncovers Novel and Targetable Vulnerabilities in the SREBP Lipid Synthesis Pathway SA Bird, A Barber, FJ Sialana, MP Licciardello, H Che, H Bouguenina, ... Blood 140 (Supplement 1), 600-601, 2022 | 4 | 2022 |
| Gliomatosis cerebri in children: A poor prognostic phenotype of diffuse gliomas with a distinct molecular profile G Nussbaumer, M Benesch, Y Grabovska, A Mackay, D Castel, J Grill, ... Neuro-oncology, noae080, 2024 | 2 | 2024 |
| INTER AND INTRA-TUMOR HETEROGENEITY OF PEDIATRIC-TYPE DIFFUSE HIGH-GRADE GLIOMA REVEALED BY HIGH-DIMENSIONAL SINGLE-CELL PROTEOMICS LL Petrilli, C Fuoco, L Pasquini, A Palma, G Pericoli, Y Grabovska, ... NEURO-ONCOLOGY 24, 71-71, 2022 | 2 | 2022 |
| ATRT-11. MOLECULAR SUBGROUPS OF ATYPICAL TERATOID/RHABDOID TUMOR (ATRT): TOWARDS A CONSENSUS M Hasselblatt, PD Johann, B Ho, Y Grabovska, F Yao, F Bourdeaut, ... Neuro-Oncology 20 (suppl_2), i29-i29, 2018 | 2 | 2018 |
| ATRT-26. AN ANALYSIS OF PUTATIVE CELLS OF ORIGIN FOR MALIGNANT RHABDOID TUMOURS (MRT): A FRONTIER FOR DEVELOPMENT OF MRT CANCER MODELLING AND IDENTIFICATION OF POTENTIAL … R Ramli, M Finetti, M Selby, Y Grabovska, S Crosier, S Bailey, S Clifford, ... Neuro-Oncology 20 (Suppl 2), i33, 2018 | 2 | 2018 |
| GABAergic neuronal lineage development determines clinically actionable targets in diffuse hemispheric glioma, H3G34-mutant I Liu, GAV Cruzeiro, L Bjerke, RF Rogers, Y Grabovska, A Beck, A Mackay, ... Cancer Cell 42 (9), 1528-1548. e17, 2024 | 1 | 2024 |
| P-179 Altered lipid metabolism in IMiD/CELMoD resistant multiple myeloma confers novel and targetable vulnerabilities S Bird, Y Xu, F Sialana, M Licciardello, H Che, S Tamin, H Bouguenina, ... Clinical Lymphoma Myeloma and Leukemia 23, S134, 2023 | 1 | 2023 |
